Shenzhen YHLO BIOTECH Co., Ltd: YHLO is a leading company of immunoassay solutions in China. Founded in 2008 and headquartered in Shenzhen China, YHLO is specialized in developing, manufacturing and distributing in-vitro diagnostic reagents and instruments for diagnosis of autoimmune diseases, reproductive health, infectious diseases and so on.
Show more
See More
About Us - Shenzhen YHLO BIOTECH Co., Ltd. YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.
Show more
See More
All Shenzhen YHLO BIOTECH Co. catalogs and technical brochures. POCT-GLINE-2019-nCoV Antigen Saliva Rapid Test. 2 Pages. POCT-Gline-2019-nCoV NAb. 2 Pages. iFlash-2019-nCoV NAb. 4 Pages. iFlash-2019-nCoV Antigen. 2 Pages.
Show more
See More
YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.
Show more
See More
Shenzhen YHLO BIOTECH Co., Ltd. (YHLO) is the leading company of Autoimmunity Solutions in China. Founded in 2008 and headquartered in Shenzhen China, together with a R&D center in Europe, YHLO is specialized in developing, manufacturing and distributing In-Vitro Diagnostic instruments and reagents by a team of high-skilled scientists and engineers.
Show more
See More
Shenzhen YHLO BIOTECH Co., Ltd. engages in developing, manufacturing, and distributing in-vitro diagnostic instruments and reagents in China. It offers clinical solutions for autoimmune, reproductive health, infectious, and other diseases; CLIA test panels, chemiluminescence immunoassay analyzers, and integration systems for immunoassay; ELISA test panels and immune analyzers; LIA …
See More
YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.
Show more
See More
Shenzhen YHLO BIOTECH Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents with own intellectual properties.
Show more
See More
Dec 02, 2016 . Shenzhen YHLO BIOTECH Co., Ltd. (YHLO) is the leading company of Autoimmunity Solutions in China. Founded in 2008 and headquartered in Shenzhen China, together with a R&D center in Europe, YHLO is specialized in developing, manufacturing and distributing In-Vitro Diagnostic instruments and reagents by a team of high-skilled scientists and engineers.
Show more
See More
Shenzhen YHLO BIOTECH Co., Ltd. 13f, Bldg A1 kexing Science Park no 15 Keyuan Rd. nanshan District. Shenzhen. 518057. China. 8675526473359. Request Info. Add to Favourite List Exhibited At: Medlab Asia & Asia Health - 2020. Medlab Middle East - 2020 ...
Show more
See More
YHLO provides extensive ELISA test menu for UNION Immune Analyzer including autoimmunity, infection, routine etc.
Show more
See More
This page offers an in-depth profile of Shenzhen YHLO BIOTECH Co Ltd, including a general overview of the company's business and key management.
Show more
See More
See Chinese trade for Shenzhen YHLO BIOTECH Co., Ltd. Complete coverage for 30 HS codes. Chinese Trade Data is another data source separate from US import data. It includes HS product codes and with their dollar values.
Show more
See More
Get information about Shenzhen YHLO BIOTECH Co dividends and ex-dividend dates. You can find more details by going to one of the sections under this page such as ex-date, dividend and payment date.
Show more
See More
Find out all of the information about the Shenzhen YHLO BIOTECH Co., Ltd. product: automated immunoassay analyzer UNION . Contact a supplier or the parent company directly to get a quote or to find out a price or your closest point of sale.
Show more
See More
Comprehensive information on women’s health issues and management, management and personalisation. Enterprise Imaging Community Supported by Agfa Healthcare Advanced and scalable radiology solutions that can help improve care coordination, increase …
Show more
See More
YHLO. 659 likes · 7 talking about this. Medical & Health
Show more
See More
Rapid Tests and Kits. COVID-19. Women's Health. Drugs of Abuse. Infectious Disease. Cardiac Markers. Tumor Markers. Other Products.
Show more
See More
Shenzhen YHLO BIOTECH Co., Ltd. (Shenzhen, China) has helped China’s top ranking hospital, Peking Union Medical College Hospital (PUMCH; Beijing, China), to successfully upgrade its laboratory from the traditional ELISA (enzyme-linked immunoassay) technology to CLIA (chemiluminescence immunoassay) technology.
YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.
As a national high-tech enterprise with many intellectual properties, YHLO’s mission is to focus on healthcare, better life with technology.
Recently, Zhongnan Hospital of Wuhan University used YHLO reagents to further analyze the protective immunity of SARS-CoV-2, which provided a basis for understanding the pathogenesis of COVID-19 and provided assistance for the development of effective SARS-CoV-2 vaccine. The research has now...
Founded in 2008 and headquartered in Shenzhen China, together with a R&D center in Europe, YHLO is specialized in developing, manufacturing and distributing In-Vitro Diagnostic instruments and reagents by a team of high-skilled scientists and engineers.
YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.
Recently, Zhongnan Hospital of Wuhan University used YHLO reagents to further analyze the protective immunity of SARS-CoV-2, which provided a basis for understanding the pathogenesis of COVID-19 and provided assistance for the development of effective SARS-CoV-2 vaccine. The research has now...
As a national high-tech enterprise with many intellectual properties, YHLO’s mission is to focus on healthcare, better life with technology.